Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.26 USD | +0.21% | -4.55% | +15.60% |
05-08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
05-07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.60% | 3.12B | |
+22.41% | 44.96B | |
+1.13% | 42.65B | |
+46.00% | 41.85B | |
-4.27% | 29.04B | |
+11.18% | 26.08B | |
-21.32% | 19.03B | |
+6.65% | 12.75B | |
+28.32% | 12.06B | |
-4.01% | 11.75B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- Wedbush Raises IDEAYA Biosciences' PT to $40 From $35 on Increased Confidence in IDE397/AMG 193 Combination, Keeps Outperform Rating